E J Frackiewicz

Summary

Affiliation: California Clinical Trials
Country: USA

Publications

  1. ncbi Women's health care during the perimenopause
    E J Frackiewicz
    California Clinical Trials, Beverly Hills, USA
    J Am Pharm Assoc (Wash) 40:800-11. 2000
  2. ncbi Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder
    E J Frackiewicz
    California Clinical Trials, Beverly Hills, CA 90211, USA
    J Am Pharm Assoc (Wash) 41:437-47. 2001
  3. ncbi Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa
    Edyta J Frackiewicz
    Briston Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA
    Ann Pharmacother 36:225-30. 2002
  4. ncbi Diagnosis and treatment of endometriosis
    Edyta J Frackiewicz
    California Clinical Trials, 8501 Wilshire Boulevard, Main Floor, Beverly Hills, CA 90211, USA
    Expert Opin Pharmacother 4:67-82. 2003
  5. ncbi Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study
    Edyta J Frackiewicz
    Howard University, Washington, DC, USA
    Psychiatry 65:371-4. 2002
  6. ncbi Review of the acetylcholinesterase inhibitor galanthamine
    J J Sramek
    California Clinical Trials, 8501 Wilshire Boulevard, 2nd Floor, Beverly Hills, CA 90211, USA
    Expert Opin Investig Drugs 9:2393-402. 2000
  7. ncbi Endometriosis: an overview of the disease and its treatment
    E J Frackiewicz
    California Clinical Trials, Beverly Hills 90211, USA
    J Am Pharm Assoc (Wash) 40:645-57; quiz 699-702. 2000
  8. ncbi Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults
    D E Salazar
    Bristol-Myers Squibb, Princeton, New Jersey, USA
    J Clin Pharmacol 41:1351-8. 2001
  9. ncbi First clinical evaluation of ganstigmine in patients with probable Alzheimer's disease
    S S Jhee
    California Clinical Trials, Beverly Hills, California USA
    Clin Neuropharmacol 26:164-9. 2003

Collaborators

Detail Information

Publications9

  1. ncbi Women's health care during the perimenopause
    E J Frackiewicz
    California Clinical Trials, Beverly Hills, USA
    J Am Pharm Assoc (Wash) 40:800-11. 2000
    ..To review the perimenopause, its associated symptoms, and current management options...
  2. ncbi Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder
    E J Frackiewicz
    California Clinical Trials, Beverly Hills, CA 90211, USA
    J Am Pharm Assoc (Wash) 41:437-47. 2001
    ..To review premenstrual disorders, their varied symptoms, possible etiology, and treatment options...
  3. ncbi Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa
    Edyta J Frackiewicz
    Briston Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA
    Ann Pharmacother 36:225-30. 2002
    ..To investigate the safety, tolerability, pharmacokinetic, and pharmacodynamic properties of the dopamine transporter antagonist brasofensine (BMS-204756) in patients with Parkinson's disease receiving levodopa/carbidopa treatment...
  4. ncbi Diagnosis and treatment of endometriosis
    Edyta J Frackiewicz
    California Clinical Trials, 8501 Wilshire Boulevard, Main Floor, Beverly Hills, CA 90211, USA
    Expert Opin Pharmacother 4:67-82. 2003
    ..Experimental treatments for endometriosis show promising preliminary results and include GnRH antagonists, aromatase inhibitors, selective oestrogen receptor modulators and mifepristone...
  5. ncbi Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study
    Edyta J Frackiewicz
    Howard University, Washington, DC, USA
    Psychiatry 65:371-4. 2002
    ..A trend toward more frequently occurring extrapyramidal symptoms among Hispanics was also found, which suggests that dosages lower than those typically recommended may be necessary in Hispanic schizophrenics...
  6. ncbi Review of the acetylcholinesterase inhibitor galanthamine
    J J Sramek
    California Clinical Trials, 8501 Wilshire Boulevard, 2nd Floor, Beverly Hills, CA 90211, USA
    Expert Opin Investig Drugs 9:2393-402. 2000
    ..Typical of AChEIs, the most common adverse events associated with GAL are nausea and vomiting. In conclusion, evidence to date suggests galanthamine to be similar to other AChEIs in improving cognitive function in AD patients...
  7. ncbi Endometriosis: an overview of the disease and its treatment
    E J Frackiewicz
    California Clinical Trials, Beverly Hills 90211, USA
    J Am Pharm Assoc (Wash) 40:645-57; quiz 699-702. 2000
    ..To review endometriosis, its etiology, clinical presentation, and current management options...
  8. ncbi Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults
    D E Salazar
    Bristol-Myers Squibb, Princeton, New Jersey, USA
    J Clin Pharmacol 41:1351-8. 2001
    ..In adults, the most common adverse effect was somnolence (21.4%); lightheadedness, nausea, vomiting, and diarrhea were also reported, although these were mild in intensity...
  9. ncbi First clinical evaluation of ganstigmine in patients with probable Alzheimer's disease
    S S Jhee
    California Clinical Trials, Beverly Hills, California USA
    Clin Neuropharmacol 26:164-9. 2003
    ..Ganstigmine, a novel cholinesterase inhibitor, was well tolerated within a dosing range of 5 to 10 mg. Once-daily dosing is supported by data on acetylcholinesterase inhibition...